No IIT degree: How Indian-origin CTOs rose to lead OpenAI, Anthropic

India, Sept. 23 -- TIME magazine has released its first-ever 'Executives of the Year: Tech & Data' list which recognises 50 leaders shaping the future of technology and artificial intelligence. Severa... Read More

Shah Rukh Khan remains India's richest actor despite net worth drop of Rs.2,500 cr, Amitabh Bachchan and Salman see growth

New Delhi, Sept. 23 -- Bollywood superstar Shah Rukh Khan's wealth has taken a hit in the last year. According to the M3M Hurun India list 2026, Khan's net worth has dropped by almost Rs.2,490 crore. ... Read More

Uyghur rights advocate urges states to prevent forced return of Uyghurs to China at UNHRC

Geneva, Sept. 23 -- Dolkun Isa, President of the Uyghur Centre for Democracy, has urged UN member states to uphold the principle of non-refoulement and ensure that Uyghurs fleeing alleged persecution ... Read More

Best camera phones under Rs. 30,000: 5 hidden photography gems

India, Sept. 23 -- Buying a camera phone under Rs.30,000 can be confusing because there are so many options available. Most phones highlight their megapixels, fast charging and powerful processors, bu... Read More

'UP free of fear, goondaism': Yogi targets SP over women's safety

India, Sept. 23 -- GORAKHPUR Chief minister Yogi Adityanath on Wednesday launched a sharp attack on the previous Samajwadi Party government over women's safety, saying that before 2017, families were ... Read More

Beats 360 launched in India with interchangeable cushions: Check price, features, availability and more

India, Sept. 23 -- Apple-owned Beats has launched its new Beats 360 over-ear headphones in India, targeting users who want a single pair for commuting, travel, work and workouts. The headphones come w... Read More

Singapore Clinical Trial: A Phase 3, two-part, double-blind, randomized, placebo-controlled study to investigate the safety and efficacy of efimosfermin alfa injection in adult participants with compensated cirrhosis (stage F4 fibrosis) due to metabolic dysfunction-associated steatohepatitis (NEBULA-2)

Singapore, Sept. 23 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, two-part, double-blind, randomized, placebo-controlled study to investigate the safety... Read More

Singapore Clinical Trial: A Phase 3, double-blind, randomized, placebo controlled, 2-arm study to investigate the safety and efficacy of efimosfermin alfa injection in adult participants with compensated cirrhosis due to metabolic dysfunction-associated steatohepatitis (NEBULA-1)

Singapore, Sept. 23 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, double-blind, randomized, placebo controlled, 2-arm study to investigate the safety an... Read More

Singapore Clinical Trial: A Phase III, Open-label, Multicentre, Randomised Study Comparing Consolidation Treatment with AZD0120, an Autologous Dual Targeting Chimeric Antigen Receptor T-cell (CAR-T) Therapy Directed Against BCMA and CD19, versus Autologous Stem Cell Transplant (ASCT) in Participants with Newly Diagnosed Multiple Myeloma who are Transplant Eligible (TE NDMM) (DURGA-6)

Singapore, Sept. 23 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Open-label, Multicentre, Randomised Study Comparing Consolidation Treatment with AZD... Read More

Singapore Clinical Trial: A Randomized, Open-label, Multicenter, Phase 3 Study to Investigate Mocertatug Rezetecan with or without Bevacizumab in Comparison to Active Observation with or without Bevacizumab as Maintenance Treatment in Participants with Newly Diagnosed FIGO Stage III/IV Non-Homologous Recombination Deficient Ovarian Cancer

Singapore, Sept. 23 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Open-label, Multicenter, Phase 3 Study to Investigate Mocertatug Rezetecan with or ... Read More

• ««
• «
• 4611
• 4612
• 4613
• 4614
• 4615
• 4616
• 4617
• 4618
• 4619
• 4620
• »
• »»